A Monoclonal Antibody Against a Murine CD38 Homologue Delivers a Signal to B Cells for Prolongation of Survival and Protection Against Apoptosis in Vitro: Unresponsiveness of X-linked Immunodeficient B Cells

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 1995 Jun 1

PMID 7642213

Citations 11

Authors

Y Yamashita

K Miyake

Y Kikuchi

K Takatsu

S Noda

A Kosugi

M Kimoto

Affiliations

Soon will be listed here.

Abstract

A novel monoclonal antibody (mAb) was established in an attempt to look for a cell-surface molecule that delivered a signal regulating apoptotic cell death of B cells. Because spleen cells in resting culture die from apoptosis, mAb were looked for that were able to prolong spleen cell survival in vitro. This screening selected mAb CS/2. CS/2 not only prolonged spleen cell survival in vitro, but also protected spleen cells from apoptotic cell death brought about by irradiation or dexamethasone. Moreover, stimulation of spleen cells with CS/2 mAb induced changes of cells to blastoid morphology, and a significant uptake of [3H]thymidine ([3H]TdR). The antigen recognized by CS/2 mAb (CS/2 Ag) was expressed on preB cells, B cells, and Mac-1+ cells. The cells surviving in vitro culture or irradiation in response to ligation with CS/2 mAb were mostly B cells expressing the CS/2 Ag. In addition, B cells from X-linked immunodeficient (XID) mice did not respond to CS/2 mAb. These results indicate that CS/2 mAb is agonistic to B cells, and that XID mice are deficient in this CS/2 mAb-mediated activation pathway. Determination of the amino-terminal 24 amino acid residues revealed that the CS/2 Ag appears to be identical to the CS/2 mAb is directed against a murine CD38 homologue, and suggest a possible role of the murine CD38 homologue in controlling apoptotic cell death of B cells.

Citing Articles

PLC-gamma2 is essential for formation and maintenance of memory B cells.

Hikida M, Casola S, Takahashi N, Kaji T, Takemori T, Rajewsky K J Exp Med. 2009; 206(3):681-9.

PMID: 19273623 PMC: 2699133. DOI: 10.1084/jem.20082100.

Interleukin-5 regulates genes involved in B-cell terminal maturation.

Horikawa K, Takatsu K Immunology. 2006; 118(4):497-508.

PMID: 16895557 PMC: 1782313. DOI: 10.1111/j.1365-2567.2006.02382.x.

Characterization and phylogenetic epitope mapping of CD38 ADPR cyclase in the cynomolgus macaque.

Ferrero E, Orciani M, Vacca P, Ortolan E, Crovella S, Titti F BMC Immunol. 2004; 5:21.

PMID: 15383153 PMC: 524171. DOI: 10.1186/1471-2172-5-21.

Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha.

Saijo K, Mecklenbrauker I, Santana A, Leitger M, Schmedt C, Tarakhovsky A J Exp Med. 2002; 195(12):1647-52.

PMID: 12070292 PMC: 2193563. DOI: 10.1084/jem.20020408.

Functional dissection of the cytoplasmic subregions of the interleukin-5 receptor alpha chain in growth and immunoglobulin G1 switch recombination of B cells.

Moon B, Yoshida T, Shiiba M, Nakao K, Katsuki M, Takaki S Immunology. 2001; 102(3):289-300.

PMID: 11298827 PMC: 1783180. DOI: 10.1046/j.1365-2567.2001.01196.x.

References

Miyake K, Hasunuma Y, Yagita H, Kimoto M . Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture. J Cell Biol. 1992; 119(3):653-62. PMC: 2289667. DOI: 10.1083/jcb.119.3.653. View

Goodnow C . Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol. 1992; 10:489-518. DOI: 10.1146/annurev.iy.10.040192.002421. View

Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F . The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993; 361(6409):226-33. DOI: 10.1038/361226a0. View

Tsukada S, Saffran D, Rawlings D, Parolini O, Allen R, Klisak I . Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993; 72(2):279-90. DOI: 10.1016/0092-8674(93)90667-f. View

Hartley S, Cooke M, Fulcher D, Harris A, Cory S, Basten A . Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell. 1993; 72(3):325-35. DOI: 10.1016/0092-8674(93)90111-3. View

Hitoshi Y, Okada Y, Sonoda E, Tominaga A, Makino M, Suzuki K . Delayed progression of a murine retrovirus-induced acquired immunodeficiency syndrome in X-linked immunodeficient mice. J Exp Med. 1993; 177(3):621-6. PMC: 2190950. DOI: 10.1084/jem.177.3.621. View

Rawlings D, Saffran D, Tsukada S, Largaespada D, Grimaldi J, Cohen L . Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 1993; 261(5119):358-61. DOI: 10.1126/science.8332901. View

Harada N, Santos-Argumedo L, Chang R, Grimaldi J, Lund F, Brannan C . Expression cloning of a cDNA encoding a novel murine B cell activation marker. Homology to human CD38. J Immunol. 1993; 151(6):3111-8. View

Santos-Argumedo L, Teixeira C, Preece G, Kirkham P, Parkhouse R . A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels. J Immunol. 1993; 151(6):3119-30. View

10.

Perandones C, Illera V, Peckham D, Stunz L, Ashman R . Regulation of apoptosis in vitro in mature murine spleen T cells. J Immunol. 1993; 151(7):3521-9. View

11.

Funaro A, De Monte L, Dianzani U, Forni M, Malavasi F . Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages. Eur J Immunol. 1993; 23(10):2407-11. DOI: 10.1002/eji.1830231005. View

12.

Howard M, Grimaldi J, Bazan J, Lund F, Santos-Argumedo L, Parkhouse R . Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science. 1993; 262(5136):1056-9. DOI: 10.1126/science.8235624. View

13.

Hitoshi Y, Sonoda E, Kikuchi Y, Yonehara S, Nakauchi H, Takatsu K . IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect. Int Immunol. 1993; 5(9):1183-90. DOI: 10.1093/intimm/5.9.1183. View

14.

von Boehmer H . Positive selection of lymphocytes. Cell. 1994; 76(2):219-28. DOI: 10.1016/0092-8674(94)90330-1. View

15.

Nossal G . Negative selection of lymphocytes. Cell. 1994; 76(2):229-39. DOI: 10.1016/0092-8674(94)90331-x. View

16.

MacLennan I . Germinal centers. Annu Rev Immunol. 1994; 12:117-39. DOI: 10.1146/annurev.iy.12.040194.001001. View

17.

Miyake K, Yamashita Y, Hitoshi Y, Takatsu K, Kimoto M . Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med. 1994; 180(4):1217-24. PMC: 2191684. DOI: 10.1084/jem.180.4.1217. View

18.

Krolick K, Isakson P, UHR J, Vitetta E . BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor. Immunol Rev. 1979; 48:81-106. DOI: 10.1111/j.1600-065x.1979.tb00299.x. View

19.

SCHER I . CBA/N immune defective mice; evidence for the failure of a B cell subpopulation to be expressed. Immunol Rev. 1982; 64:117-36. DOI: 10.1111/j.1600-065x.1982.tb00421.x. View

20.

Coffman R . Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol Rev. 1982; 69:5-23. DOI: 10.1111/j.1600-065x.1983.tb00446.x. View